Medication-overuse headache: Bridging therapies for detoxification

Medication-overuse headache (MOH) or rebound headache is caused by frequent use of acute pain medications and often complicates chronic migraine. The exact cause for this association remains unknown but is likely to represent complex interplay between psychosocial factors, class of medication overused and the presence of polymorphic gene variants of pain pathways involved in migraine. The most important treatment strategy for MOH is withdrawal (also known as detoxification) of the overused acute medication, which has repeatedly been shown to achieve a significant reduction in monthly headache days at 8 weeks. Reducing or stopping acute medication, however, typically worsens pre-existing headache and depending on the class of medication overused, may also cause psychological and physical symptoms. Numerous 'bridging' therapies have been used to try and reduce the frequency and intensity of withdrawal headaches and the severity of accompanying symptoms to aid successful withdrawal. The aim of this narrative review was to examine the withdrawal process for different classes of acute medication and examine different pharmacological and non-pharmacological bridging therapies in MOH.

Authors

Institutions

Publication Details

Journal
Clinical Neurology and Neurosurgery
Published
2025-10-25
DOI
https://doi.org/10.1016/j.clineuro.2025.109205
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medication-overuse headache: Bridging therapies for detoxification

Prut Koonalintip, Benjamin R. Wakerley
Clinical Neurology and Neurosurgery
Migraine and Headache Studies
article

Medication-overuse headache: Bridging therapies for detoxification

Prut Koonalintip, Benjamin R. Wakerley
article en

Abstract

Medication-overuse headache (MOH) or rebound headache is caused by frequent use of acute pain medications and often complicates chronic migraine. The exact cause for this association remains unknown but is likely to represent complex interplay between psychosocial factors, class of medication overused and the presence of polymorphic gene variants of pain pathways involved in migraine. The most important treatment strategy for MOH is withdrawal (also known as detoxification) of the overused acute medication, which has repeatedly been shown to achieve a significant reduction in monthly headache days at 8 weeks. Reducing or stopping acute medication, however, typically worsens pre-existing headache and depending on the class of medication overused, may also cause psychological and physical symptoms. Numerous 'bridging' therapies have been used to try and reduce the frequency and intensity of withdrawal headaches and the severity of accompanying symptoms to aid successful withdrawal. The aim of this narrative review was to examine the withdrawal process for different classes of acute medication and examine different pharmacological and non-pharmacological bridging therapies in MOH.

Clinical Neurology and NeurosurgeryVol. 259
Prince of Songkla University (TH), University of Birmingham (GB)
Openalex Percentile: Top 63%
Migraine and Headache Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Medication-overuse headache: Bridging therapies for detoxification — Prut Koonalintip, Benjamin R. Wakerley · Clinical Neurology and Neurosurgery (2025) | TGRS Research Map | TGRS